Generation of reassortants between African arenaviruses
- PMID: 1585636
- DOI: 10.1016/0042-6822(92)90514-p
Generation of reassortants between African arenaviruses
Abstract
Lassa (LAS) and Mopeia (MOP) viruses are African arenaviruses which are carried by wild rodents and occasionally transferred to humans. In humans and nonhuman primates, Lassa causes mortality in 60% of untreated cases, whereas Mopeia does not cause mortality and has been known to protect monkeys from lethal challenge with Lassa. These two African arenaviruses also differ in their lethality for suckling outbred mice and in their plaque sizes under agar overlay. MOP virus induces small plaques and lethal infection after intracerebral (ic) inoculation. In contrast, LAS inoculation does not kill mice and the virus induces large plaques. After coinfection of Vero cells with LAS and MOP viruses some phenotypic reassortants which produced small plaques and were not lethal for outbred mice were isolated and plaque-purified. Dot-blot hybridization using LAS and MOP cDNA probes specific for L and S RNA segments revealed a genotype consisting of the L RNA of MOP and the S RNA of LAS (MOP/LAS reassortant). Adoptive transfer experiments demonstrated an ability of immune splenocytes from CBA mice intraperitoneally infected with the MOP/LAS reassortants to protect recipient mice against lethal disease after ic inoculation with LAS virus.
Similar articles
-
[The isolation and characteristics of reassortants between the Lassa and Mopeia arenaviruses].Vopr Virusol. 1991 Mar-Apr;36(2):146-50. Vopr Virusol. 1991. PMID: 1882522 Russian.
-
Molecular characterization of a reassortant virus derived from Lassa and Mopeia viruses.Virus Genes. 2007 Apr;34(2):169-76. doi: 10.1007/s11262-006-0050-3. Epub 2006 Dec 2. Virus Genes. 2007. PMID: 17143722 Free PMC article.
-
A live attenuated vaccine for Lassa fever made by reassortment of Lassa and Mopeia viruses.J Virol. 2005 Nov;79(22):13934-42. doi: 10.1128/JVI.79.22.13934-13942.2005. J Virol. 2005. PMID: 16254329 Free PMC article.
-
Phylogeny and evolution of old world arenaviruses.Virology. 2006 Jul 5;350(2):251-7. doi: 10.1016/j.virol.2006.01.026. Epub 2006 Feb 21. Virology. 2006. PMID: 16494913 Review.
-
Recombination and gene coding assignments of bunyaviruses and arenaviruses.Ann N Y Acad Sci. 1980;354:84-106. doi: 10.1111/j.1749-6632.1980.tb27960.x. Ann N Y Acad Sci. 1980. PMID: 7013623 Review. No abstract available.
Cited by
-
An attenuated Lassa vaccine in SIV-infected rhesus macaques does not persist or cause arenavirus disease but does elicit Lassa virus-specific immunity.Virol J. 2013 Feb 12;10:52. doi: 10.1186/1743-422X-10-52. Virol J. 2013. PMID: 23402317 Free PMC article.
-
Vaccine Platforms to Control Arenaviral Hemorrhagic Fevers.J Vaccines Vaccin. 2012 Nov 20;3(7):1000160. doi: 10.4172/2157-7560.1000160. J Vaccines Vaccin. 2012. PMID: 23420494 Free PMC article.
-
Vaccination strategies against highly pathogenic arenaviruses: the next steps toward clinical trials.PLoS Pathog. 2013;9(4):e1003212. doi: 10.1371/journal.ppat.1003212. Epub 2013 Apr 11. PLoS Pathog. 2013. PMID: 23592977 Free PMC article. Review.
-
Lassa Virus Countermeasures.Curr Top Microbiol Immunol. 2023;440:111-145. doi: 10.1007/82_2022_261. Curr Top Microbiol Immunol. 2023. PMID: 36253593
-
Imported lassa fever in Germany: molecular characterization of a new lassa virus strain.Emerg Infect Dis. 2000 Sep-Oct;6(5):466-76. doi: 10.3201/eid0605.000504. Emerg Infect Dis. 2000. PMID: 10998376 Free PMC article.
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Other Literature Sources